🇺🇸 FDA
Patent

US 8591890

Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality

granted A61KA61K2039/6043A61K31/135

Quick answer

US patent 8591890 (Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality) held by University of Connecticut Health Center expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
University of Connecticut Health Center
Grant date
Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
59
CPC classes
A61K, A61K2039/6043, A61K31/135, A61K31/196, A61K31/277